Scientists have developed a breakthrough therapy that could revolutionise the treatment of high cholesterol, which currently ...

A new DNA-based therapy could cut cholesterol nearly in half—without relying on statins or causing side effects.

Merck , known as MSD outside of the United States and Canada, today announced plans to present new research from the company's cardio-pulmonary portfolio and pipeline at the American Heart Association ...

McMaster researchers found that deep abdominal and liver fat can quietly damage arteries, even in people who appear fit.

Given that polygenic risk doesn’t change and only needs to be measured once, researchers advocate greater use.